Parallel Advisors’s LeonaBio Inc LONA Stock Holding History

Parallel Advisors’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20	Closed	-$3K	–	2957
2021 Q4	$3K	Sell	20 -48	-71%	-$6.07K	﹤0.01%	2548
2021 Q3	$6K	Buy	+68	New	+$6.92K	﹤0.01%	2269

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Parallel Advisors's LONA Position: Q1 2022 in Review

Parallel Advisors sold out of LeonaBio Inc (LONA) in Q1 2022, closing a stake of 20 shares — an estimated $3K sold.

Parallel Advisors first reported a position in LONA in Q3 2021 and held it in 2 quarters. The position peaked at $6K in Q3 2021. 105 funds tracked by Wall St. Rank hold LONA as of Q1 2022.

Parallel Advisors reported no remaining LeonaBio Inc position as of Q1 2022 after selling out during the quarter.
Parallel Advisors sold 20 LeonaBio Inc shares in Q1 2022, an estimated $3K.
Parallel Advisors first reported a position in LeonaBio Inc in Q3 2021 and held it in 2 quarters.
Parallel Advisors's LeonaBio Inc position peaked at $6K in Q3 2021.
105 funds tracked by Wall St. Rank held LeonaBio Inc as of Q1 2022.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.